We propose to investigate the hypothesis that the chronic tissue damage associated with long-term diabetes mellitus may arise in part from in situ immune complex formation by accumulated immunoglobulins and/or antigens covalently bound to long-lived structural proteins which have undergone excessive nonenzymatic glycosylation with subsequent generation of reactive carbonyls. In the diabetic kidney, such immobilized immune complexes may serve as a chronic stimulus for tissue destruction by macrophages.
The specific aims of the studies described in this proposal are to: I) Characterize the covalent trapping of lysine and proteins by nonenzymatically glycosylated collagen (chemical and kinetic studies), using soluble collagen immobilized on Agarose. The effect of time and reactant concentrations will be evaluated, and binding will be assessed both in vitro and in vivo; II) Quantitate in situ formation of immune complexes by antigen or antibody bound covalently to nonenzymatically glycosylated collagen, using radioiodinated soluble proteins; II) Investigate the effect of immune complexes bound to glycosylated collagen on macrophage tissue-injury mechanisms. Phagocytosis will be evaluated using antibody-sensitized sheep erythrocytes labelled with 51Cr, and hydrolytic enzyme secretion will be investigated by measuring selected glycohydrolases, neutral proteases, and plasminogen activator; IV) Evaluate the effect of diabetes and high in vitro glucose concentration on macrophage response to nonenzymatically glycosylated collagen-bound immune complexes. Results from these studies may provide a basis for future development of new therapeutic agents useful in the treatment of diabetic complications.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK033861-03
Application #
3232260
Study Section
(SSS)
Project Start
1984-04-01
Project End
1987-03-31
Budget Start
1986-04-01
Budget End
1987-03-31
Support Year
3
Fiscal Year
1986
Total Cost
Indirect Cost
Name
Rockefeller University
Department
Type
Graduate Schools
DUNS #
071037113
City
New York
State
NY
Country
United States
Zip Code
10065
Giacco, Ferdinando; Du, Xueliang; CarratĂș, Anna et al. (2015) GLP-1 Cleavage Product Reverses Persistent ROS Generation After Transient Hyperglycemia by Disrupting an ROS-Generating Feedback Loop. Diabetes 64:3273-84
Giacco, Ferdinando; Du, Xueliang; D'Agati, Vivette D et al. (2014) Knockdown of glyoxalase 1 mimics diabetic nephropathy in nondiabetic mice. Diabetes 63:291-9
Golovchenko, I; Goalstone, M L; Watson, P et al. (2000) Hyperinsulinemia enhances transcriptional activity of nuclear factor-kappaB induced by angiotensin II, hyperglycemia, and advanced glycosylation end products in vascular smooth muscle cells. Circ Res 87:746-52
Nishikawa, T; Giardino, I; Edelstein, D et al. (2000) Changes in diabetic retinal matrix protein mRNA levels in a common transgenic mouse strain. Curr Eye Res 21:581-7
Du, X L; Edelstein, D; Rossetti, L et al. (2000) Hyperglycemia-induced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogen activator inhibitor-1 expression by increasing Sp1 glycosylation. Proc Natl Acad Sci U S A 97:12222-6
Hammes, H P; Brownlee, M; Lin, J et al. (1999) Diabetic retinopathy risk correlates with intracellular concentrations of the glycoxidation product Nepsilon-(carboxymethyl) lysine independently of glycohaemoglobin concentrations. Diabetologia 42:603-7
Shinohara, M; Thornalley, P J; Giardino, I et al. (1998) Overexpression of glyoxalase-I in bovine endothelial cells inhibits intracellular advanced glycation endproduct formation and prevents hyperglycemia-induced increases in macromolecular endocytosis. J Clin Invest 101:1142-7
Giardino, I; Fard, A K; Hatchell, D L et al. (1998) Aminoguanidine inhibits reactive oxygen species formation, lipid peroxidation, and oxidant-induced apoptosis. Diabetes 47:1114-20
Giardino, I; Edelstein, D; Brownlee, M (1996) BCL-2 expression or antioxidants prevent hyperglycemia-induced formation of intracellular advanced glycation endproducts in bovine endothelial cells. J Clin Invest 97:1422-8
Hammes, H P; Brownlee, M; Jonczyk, A et al. (1996) Subcutaneous injection of a cyclic peptide antagonist of vitronectin receptor-type integrins inhibits retinal neovascularization. Nat Med 2:529-33

Showing the most recent 10 out of 15 publications